Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Keith J. Johnson Insider Profile
4 Followers
Keith J. Johnson, Director at Sonnet BioTherapeutics Holdings, holds 397.88K shares in Amergent Hospitality Group (Ticker: AMHG), holds 38.64K shares in Sonnet BioTherapeutics Holdings (Ticker: SONN).
Keith J. Johnson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Keith J. Johnson holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Keith J. Johnson
Keith J. Johnson's Trading History
Sonnet BioTherapeutics Holdings
May 14, 2019
Director
Uninformative Buy
―
$69.93K
Amergent Hospitality Group
Apr 07, 2023
Director
Uninformative Buy
―
$39.79K
List of latest transactions for each holding click on a transaction to see Keith J. Johnson's performance on stock
You May Also Like
Keith J. Johnson insider profile FAQ
What is the percentage of profitable transactions made by Keith J. Johnson?
The percentage of profitable transactions made by Keith J. Johnson is ―.
What is the average return per transaction made by Keith J. Johnson?
The average return per transaction made by Keith J. Johnson is ―.
What stocks does Keith J. Johnson hold?
Keith J. Johnson holds: SONN, AMHG stocks.
What was Keith J. Johnson’s latest transaction?
Keith J. Johnson latest transaction was an Uninformative Buy of ―.
What was Keith J. Johnson's most profitable transaction?
Keith J. Johnson’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Keith J. Johnson's role in Sonnet BioTherapeutics Holdings?
Keith J. Johnson's role in Sonnet BioTherapeutics Holdings is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.